| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780326 | Gynecologic Oncology | 2018 | 8 Pages |
Abstract
Due to their rarity, the majority of EPSCC-GTs are understudied and poorly understood. As demonstrated in the case of SCCOHT, unraveling the mutational profiles of these tumors can lead to improved diagnosis and the identification of novel therapeutic targets.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jay R. Patibandla, Julia E. Fehniger, Douglas A. Levine, Petar Jelinic,